mci 9038 has been researched along with B16 Melanoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asanuma, K; Hayashi, T; Kusuzaki, K; Matsumine, A; Okuyama, N; Seto, M; Suzuki, K; Uchida, A; Wakabayashi, H | 1 |
1 other study(ies) available for mci 9038 and B16 Melanoma
| Article | Year |
|---|---|
Thrombin inhibitor, argatroban, prevents tumor cell migration and bone metastasis.
Topics: Animals; Antineoplastic Agents; Antithrombins; Arginine; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Dose-Response Relationship, Drug; Melanoma, Experimental; Mice; Pipecolic Acids; Sulfonamides | 2004 |